(114 days)
The mesh implant is intended for use as a suburethral sling for the treatment of stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
The proposed device is a sterile, single use device, consisting of a synthetic mesh sling assembly and packaged with a delivery device. The mesh assembly consists of a knitted polypropylene monofilament fiber mesh body with polypropylene carriers, each are attached to separate ends.
This document describes a 510(k) premarket notification for a Surgical Mesh (SIS), seeking substantial equivalence to existing predicate devices. It does not contain information about acceptance criteria or a study proving that a device meets specific performance metrics in the way a diagnostic AI device submission would.
Instead, this submission establishes substantial equivalence based on:
- Intended Use: The proposed device has the same intended use as the predicate devices: "a suburethral sling for the treatment of stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency."
- Technological Characteristics: The proposed device has "the same and/or equivalent technological characteristics (i.e. mesh design and mesh material)" as the predicate(s).
- Performance Characteristics: The submission states that "performance characteristics tested" demonstrated substantial equivalence. However, the details of these performance characteristics or the specific tests conducted are not provided in this excerpt.
Therefore, I cannot provide the requested information in the format of a table of acceptance criteria and reported device performance, nor can I answer questions about sample sizes, ground truth establishment, or expert involvement, as this information is not present in the provided 510(k) summary.
In summary, the provided document is a regulatory filing asserting substantial equivalence based on intended use, technological characteristics, and general performance, rather than a detailed study report with specific acceptance criteria and outcome data for a new, novel AI device or a device with new performance claims.
{0}------------------------------------------------
K081275
pg 1 of 2
510(k) Summary for Surgical Mesh
A. Sponsor
Boston Scientific Corporation Urology and Gynecology Division 100 Boston Scientific Way Marlborough, MA 01756
B. Contact
Janet A. McGrath Principal Regulatory Affairs Specialist 508-683-4726 or Donna Gardner Director, Regulatory Affairs 508-683-4398
C. Device Name
Tradename: Surgical Mesh, (SIS) Common/usual name: Surgical Mesh Classification Namer 7447 - Mesh, Surgical, Polymeric 21 CFR 878.3300, Class II
D. Predicate Device(s)
Tradename:
Advantage® Transvaginal Mid Urethral Sling System Advantage Fit™ System Lynx ® Suprapubic Mid Urethral Sling System Obtryx® Transobturator Mid Urethral Sling System Prefyx PPS® System AMS MiniArcTM Sling System
Common/usual name: Surgical Mesh Classification Name: (PAH) - Mesh, Surgical, Polymeric 21 CFR 878.3300, Class II
Premarket
Notification: Boston Scientific Corporation: K020110. K040787 American Medical System.Inc .: K073703
E. Device Description
The proposed device is a sterile, single use device, consisting of a synthetic mesh sling assembly and packaged with a delivery device. The mesh assembly consists of a knitted polypropylene monofilament fiber mesh body with polypropylene carriers, each are attached to separate ends.
Accessories
The proposed mesh sling configuration is packaged with other legally marketed accessories (e.g., Delivery Device; Class I exempt: 876.4730 Manual gastroenterology-urology surgical instrument and accessories).
AUG 2.7 2008
{1}------------------------------------------------
K081275
kg 2022
F. Intended Use
The mesh implant is intended for use as a suburethral sling for the treatment of stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
G. Technological Characteristics
The proposed device has the same and/or equivalent technological characteristics (i.e. mesh design and mesh material) as the predicate(s).
H. Substantial Equivalence
Utilizing FDA's Guidance for Industry and FDA Staff "Format for Traditional and Abbreviated 510(k)s" and "Guidance for the Preparation of a Premarket Notification Application for a Surgical Mesh", a direct comparison of key characteristics demonstrates that the proposed mesh is substantially equivalent to the predicate mesh in terms of intended use, technological characteristics, and performance characteristics tested. The proposed device is as safe, as effective, and performs as well as the predicate device.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle faces right, and its head is slightly tilted upwards. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular fashion around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Ms. Janet A. McGrath Principal Regulatory Affairs Specialist Boston Scientific Corporation 100 Boston Scientific Way MARLBOROUGH MA 01752
SEP 2 8 2012
K081275 Re: Trade/Device Name: Surgical Mesh, (SIS) Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: PAH Dated: August 13, 2008 Received: August 14, 2008
Dear Ms. McGrath:
This letter corrects our substantially equivalent letter of August 27, 2008.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
{3}------------------------------------------------
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Benjamin R. Runkle
Benjamin R. Fisher, Ph.D. Director Division of Reproductive. Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use Statement
510(k) Number (if Known): K081275
Device Name: Surgical Mesh , (SIS)
Indications For Use:
The mesh implant is intended for use as a suburethral sling for the treatment of stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency.
Prescription Use ਮ (21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
5
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of General. Restorative, and Neurosogical Devices
510(k) Number
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.